Skip to content
10-Q

Quarterly Report

Phathom Pharmaceuticals, Inc. PHAT

0000950170-25-104548

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 70.94M sh
Shares Diluted Q2 2025 · Jun 30, 2025 72.47M sh
Shares Diluted Q2 2025 · Jun 30, 2025 72.22M sh
Shares Diluted Q2 2025 · Jun 30, 2024 58.56M sh
Shares Diluted Q2 2025 · Jun 30, 2024 58.46M sh
Capex Q2 2025 · Jun 30, 2025 $115K
Capex Q2 2025 · Jun 30, 2024 $86K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$147.66M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$139.74M
Long Term Debt Q2 2025 · Jun 30, 2025 $205.14M
Long Term Debt Q2 2025 · Dec 31, 2024 $201.41M
Short Term Debt Q2 2025 · Jun 30, 2025 $0
Short Term Debt Q2 2025 · Dec 31, 2024 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $149.57M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $297.26M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$405.83M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$338.38M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$253.58M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$233.83M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$148.5M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$72.76M
Current Liabilities Q2 2025 · Jun 30, 2025 $91.82M
Current Liabilities Q2 2025 · Dec 31, 2024 $85.73M
Total Liabilities Q2 2025 · Jun 30, 2025 $656.05M
Total Liabilities Q2 2025 · Dec 31, 2024 $631.9M
Current Assets Q2 2025 · Jun 30, 2025 $218.88M
Current Assets Q2 2025 · Dec 31, 2024 $360.13M
Total Assets Q2 2025 · Jun 30, 2025 $250.22M
Total Assets Q2 2025 · Dec 31, 2024 $378.32M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.05
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.36
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.56
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.98
Eps Basic Q2 2025 · Jun 30, 2025 −$1.05
Eps Basic Q2 2025 · Jun 30, 2025 −$2.36
Eps Basic Q2 2025 · Jun 30, 2024 −$1.56
Eps Basic Q2 2025 · Jun 30, 2024 −$2.98
Sga Expense Q2 2025 · Jun 30, 2025 $85.31M
Sga Expense Q2 2025 · Jun 30, 2025 $179.79M
Sga Expense Q2 2025 · Jun 30, 2024 $75.87M
Sga Expense Q2 2025 · Jun 30, 2024 $137.88M
Rd Expense Q2 2025 · Jun 30, 2025 $9.08M
Rd Expense Q2 2025 · Jun 30, 2025 $18.26M
Rd Expense Q2 2025 · Jun 30, 2024 $7.38M
Rd Expense Q2 2025 · Jun 30, 2024 $16.81M
Net Income Q2 2025 · Jun 30, 2025 −$75.81M
Net Income Q2 2025 · Jun 30, 2025 −$170.13M
Net Income Q2 2025 · Mar 31, 2025 −$94.32M
Net Income Q2 2025 · Jun 30, 2024 −$91.45M
Net Income Q2 2025 · Jun 30, 2024 −$174.3M
Net Income Q2 2025 · Mar 31, 2024 −$82.85M
Operating Income Q2 2025 · Jun 30, 2025 −$59.92M
Operating Income Q2 2025 · Jun 30, 2025 −$138.79M
Operating Income Q2 2025 · Jun 30, 2024 −$77.3M
Operating Income Q2 2025 · Jun 30, 2024 −$147.25M
Gross Profit Q2 2025 · Jun 30, 2025 $34.47M
Gross Profit Q2 2025 · Jun 30, 2025 $59.26M
Gross Profit Q2 2025 · Jun 30, 2024 $5.95M
Gross Profit Q2 2025 · Jun 30, 2024 $7.43M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $5.04M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $8.76M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.38M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.8M
Revenue Q2 2025 · Jun 30, 2025 $39.5M
Revenue Q2 2025 · Jun 30, 2025 $68.02M
Revenue Q2 2025 · Jun 30, 2024 $7.32M
Revenue Q2 2025 · Jun 30, 2024 $9.24M